Patient-derived lymphomoids preserve the tumor architecture and allow to assess response to therapies in lymphoma
Albert Santamaria‐Martínez, Justine Epiney, Divyanshu Srivastava, Daniele Tavernari, Marco Varrone, Dina Milowich, Igor Letovanec, Thorsten Krueger, Rafael Durán, Giovanni Ciriello, Anne Cairoli, Elisa Oricchio
This study develops lymphomoids from patient lymphoma samples to assess therapy response, showing consistency with clinical outcomes.
Nature Communications · Dec 9, 2024Peer-reviewedCancer Biology